Protective T cell-independent antiviral antibody responses are dependent on complement

Journal of Experimental Medicine

Volumn 190, Issue 8, 1999, Pages 1165-1174

  Ochsenbein, Adrian F ^a,c   Pinschewer, Daniel D ^a   Odermatt, Bernhard ^a   Carroll, Michael C ^b   Hengartner, Hans ^a   Zinkernagel, Rolf M ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b HARVARD MEDICAL SCHOOL   (United States)

^c INSTITUTE OF EXPERIMENTAL IMMUNOLOGY   (Switzerland)

Author keywords

Antiviral immunity; CD19; Complement; Neutralizing antibodies; T cell independence

Indexed keywords

ANIMAL CELL; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; CELL PROTECTION; CELL STIMULATION; COMPLEMENT ACTIVATION; COMPLEMENT DEFICIENCY; EFFECTOR CELL; IMMUNOGENICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TARGET CELL; VIRUS NEUTRALIZATION; VIRUS RECOMBINANT;

ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; COMPLEMENT C3; COMPLEMENT C4; COMPLEMENT SYSTEM PROTEINS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MICE; MICE, KNOCKOUT; POLIOVIRUS; RECEPTORS, COMPLEMENT; SPLEEN; T-LYMPHOCYTES; VACCINIA VIRUS; VESICULAR STOMATITIS-INDIANA VIRUS;

EID: 0032753625     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.190.8.1165     Document Type: Article

References (58)

1. Wessels, M.R., P. Butko, M. Ma, H.B. Warren, A.L. Lage, and M.C. Carroll. 1995. Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Proc. Natl. Acad. Sci. USA. 92: 11490-11494.
2. Holland, S.M., and J.I. Gallin. 1998. Evaluation of the patient with recurrent bacterial infections. Annu. Rev. Med. 49: 185-199.
3. Lachmann, P.J., and A. Davies. 1997. Complement and immunity to viruses. Immunol. Rev. 159:69-77.
4. Stoiber, H., A. Clivio, and M.P. Dierich. 1997. Role of complement in HIV infection. Annu. Rev. Immunol. 15: 649-674.
5. Carter, R.H., and D.T. Fearon. 1992. CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science. 256:105-107.
6. Van Noesel, C.J., A.C. Lankester, and R.A. Van Lier. 1993. Dual antigen recognition by B cells. Immunol. Today. 14:8-11.
7. Tedder, T.F., L.J. Zhou, and P. Engel. 1994. The CD19/ CD21 signal transduction complex of B lymphocytes. Immunol. Today. 15:437-442.
8. Fearon, D.T., and R.H. Carter. 1995. The CD19/CR2/ TAPA-1 complex of B lymphocytes: linking natural to acquired immunity. Annu. Rev. Immunol. 13:127-149.
9. Fearon, D.T., and R.M. Locksley. 1996. The instructive role of innate immunity in the acquired immune response. Science. 272:50-54.
10. Carroll, M.C. 1998. The role of complement and complement receptors in induction and regulation of immunity. Annu. Rev. Immunol. 16:545-568.
11. Berry, D.M., and J.D. Almeida. 1968. The morphological and biological effects of various antisera on avian infectious bronchitis virus. J. Gen. Virol. 3:97-102.
12. Sissons, J.G., M.B. Oldstone, and R.D. Schreiber. 1980. Antibody-independent activation of the alternative complement pathway by measles virus-infected cells. Proc. Natl. Acad. Sci. USA. 77:559-562.
13. Frade, R., M. Barel, B. Ehlin-Henriksson, and G. Klein. 1985. gp140, the C3d receptor of human B lymphocytes, is also the Epstein-Barr virus receptor. Proc. Natl. Acad. Sci. USA. 82:1490-1493.
14. Pepys, M.B. 1972. Role of complement in induction of the allergic response. Nat. New Biol. 237:157-159.
15. Heyman, B., E.J. Wiersma, and T. Kinoshita. 1990. In vivo inhibition of the antibody response by a complement receptor-specific monoclonal antibody. J. Exp. Med. 172:665-668.
16. Hebell, T., J.M. Ahearn, and D.T. Fearon. 1991. Suppression of the immune response by a soluble complement receptor of B lymphocytes. Science. 254:102-105.
17. Gustavsson, S., T. Kinoshita, and B. Heyman. 1995. Antibodies to murine complement receptor 1 and 2 can inhibit the antibody response in vivo without inhibiting T helper cell induction. J. Immunol. 154:6524-6528.
18. Ahearn, J.M., M.B. Fischer, D. Croix, S. Goerg, M. Ma, J. Xia, X. Zhou, R.G. Howard, T.L. Rothstein, and M.C. Carroll. 1996. Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity. 4:251-262.
19. Molina, H., V.M. Holers, B. Li, Y. Fung, S. Mariathasan, J. Goellner, J. Strauss-Schoenberger, R.W. Karr, and D.D. Chaplin. 1996. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc. Natl. Acad. Sci. USA. 93:3357-3361.
20. Fischer, M.B., M. Ma, S. Goerg, X. Zhou, J. Xia, O. Finco, S. Han, G. Kelsoe, R.G. Howard, T.L. Rothstein, et al. 1996. Regulation of the B cell response to T-dependent antigens by classical pathway complement. J. Immunol. 157: 549-556.
21. Dempsey, P.W., E.D. Allison, S. Akkaraju, C.C. Goodnow, and D.T. Fearon. 1996. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science. 271:348-350.
22. Papamichail, M., C. Gutierrez, P. Embling, P. Johnson, E.J. Holborow, and M.B. Pepys. 1975. Complement dependence of localisation of aggregated IgG in germinal centres. Scand. J. Immunol. 4:343-347.
23. Klaus, G.G., J.H. Humphrey, A. Kunkl, and D.W. Dongworth. 1980. The follicular dendritic cell: its role in antigen presentation in the generation of immunological memory. Immunol. Rev. 53:3-28.
24. Fischer, M.B., S. Goerg, L. Shen, A.P. Prodeus, C.C. Goodnow, G. Kelsoe, and M.C. Carroll. 1998. Dependence of germinal center B cells on expression of CD21/CD35 for survival. Science. 280:582-585.
25. Rickert, R.C., K. Rijewsky, and J. Roes. 1995. Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature. 376:352-355.
26. Mond, J.J., A. Lees, and C.M. Snapper. 1995. T cell-independent antigens type 2. Annu. Rev. Immunol. 13:655-692.
27. Bachmann, M.F., H. Hengartner, and R.M. Zinkernagel. 1995. T helper cell-independent neutralizing B cell response against vesicular stomatitis virus: role of antigen patterns in B cell induction? Eur. J. Immunol. 25:3445-3451.
28. Baer, G.M., W.J. Bellini, and D.B. Fishbein. 1990. Rhabdoviruses. In Virology. B.N. Fields and D.M. Knipe, editors. Raven Press, New York.
29. Wagner, R.R. 1987. The Rhabdoviruses. Plenum Press, New York. 1-544.
30. Christian, A.Y., M. Barna, Z. Bi, and C.S. Reiss. 1996. Host immune response to vesicular stomatitis virus infection of the central nervous system in C57BL/6 mice. Viral Immunol. 9:195-205.
31. Bachmann, M.F., H. Hengartner, and R.M. Zinkernagel. 1997. Neutralizing anti-viral B cell responses. Annu. Rev. Immunol. 15:235-270.
32. Matsuura, Y., R.D. Possee, H.A. Overton, and D.H. Bishop. 1987. Baculovirus expression vectors: the requirements for high level expression of proteins, including glycoproteins. J. Gen. Virol. 68:1233-1250.
33. Fehr, T., R.C. Rickert, B. Odermatt, J. Roes, K. Rajewsky, H. Hengartner, and R.M. Zinkernagel. 1998. Antiviral protection and germinal center formation, but impaired B cell memory in the absence of CD19. J. Exp. Med. 188:145-155.
34. Leist, T.P., S.P. Cobbold, H. Waldmann, M. Aguet, and R.M. Zinkernagel. 1987. Functional analysis of T lymphocyte subsets in antiviral host defense. J. Immunol. 138:2278-2281.
35. van Vliet, E., M. Melis, and W. van Ewijk. 1985. Marginal zone macrophages in the mouse spleen identified by a monoclonal antibody. Anatomical correlation with a B cell subpopulation. J. Histochem. Cytochem. 33:40-44.
36. Bachmann, M.F., T.M. Kündig, C.P. Kalberer, H. Hengartner, and R.M. Zinkernagel. 1994. How many specific B cells are needed to protect against a virus? J. Immunol. 152:4235-4241.
37. Bachmann, M.F., T.M. Kündig, C.P. Kalberer, H. Hengartner, and R.M. Zinkernagel. 1993. Formalin inactivation of vesicular stomatitis virus impairs T-cell-but not T-help-independent B-cell responses. J. Virol. 67:3917-3922.
38. Müller, U., U. Steinhoff, L.F. Reis, S. Hemmi, J. Pavlovic, R.M. Zinkernagel, and M. Aguet. 1994. Functional role of type I and type II interferons in antiviral defense. Science. 264: 1918-1921.
39. Steinhoff, U., U. Müller, A. Schertler, H. Hengartner, M. Aguet, and R.M. Zinkernagel. 1995. Antiviral protection by vesicular stomatitis virus-specific antibodies in alpha/beta interferon receptor-deficient mice. J. Virol. 69:2153-2158.
40. Thomsen, A.R., A. Nansen, C. Anderson, J. Johansen, O. Marker, and J.P. Christensen. 1997. Cooperation of B cells and T cells is required for survival of mice infected with vesicular stomatitis virus. Int. Immunol. 9:1757-1766.
41. Scott, D.W., and R.K. Gershon. 1970. Determination of total and mercaptoethanol-resistant antibody in the same serum sample. Clin. Exp. Immunol. 6:313-316.
42. Fehr, T., M.F. Bachmann, H. Bluethmann, H. Kikutani, H. Hengartner, and R.M. Zinkernagel. 1996. T-independent activation of B cells by vesicular stomatitis virus: no evidence for the need of a second signal. Cell. Immunol. 168:184-192.
43. Carroll, M.C. 1998. The role of complement and complement receptors in induction and regulation of immunity. Annu. Rev. Immunol. 16:545-568.
44. Brown, E.J. 1991. Complement receptors and phagocytosis. Curr. Opin. Immunol. 3:76-82.
45. Roost, H.-P., M.F. Bachmann, A. Haag, U. Kalinke, V. Pliska, H. Hengartner, and R.M. Zinkernagel. 1995. Early high-affinity neutralizing anti-viral IgG responses without further overall improvements of affinity. Proc. Natl. Acad. Sci. USA. 92:1257-1261.
46. Welsh, R.M., Jr., and R.M. Zinkernagel. 1977. Heterospecific cytotoxic cell activity induced during the first three days of acute lymphocytic choriomeningitis virus infection in mice. Nature. 268:646-648.
47. Tew, J.G., M.H. Kosco, G.F. Burton, and A.K. Szakal. 1990. Follicular dendritic cells as accessory cells. Immunol. Rev. 117: 185-211.
48. Ebenbichler, C.F., N.M. Thielens, R. Vornhagen, P. Marschang, G.J. Arlaud, and M.P. Dierich. 1991. Human immunodeficiency virus type 1 activates the classical pathway of complement by direct C1 binding through specific sites in the transmembrane glycoprotein gp41. J. Exp. Med. 174: 1417-1424.
49. Gobet, R., A. Cerny, E. Rüedi, H. Hengartner, and R.M. Zinkernagel. 1988. The role of antibodies in natural and acquired resistance of mice to vesicular stomatitis virus. Exp. Cell Biol. 56:175-180.
50. Beebe, D.P., and N.R. Cooper. 1981. Neutralization of vesicular stomatitis virus (VSV) by human complement requires a natural IgM antibody present in human serum. J. Immunol. 126:1562-1568.
51. Welsh, R.M. 1977. Host cell modification of lymphocytic choriomeningitis virus and Newcastle disease virus altering viral inactivation by human complement. J. Immunol. 118: 348-354.
52. Takefman, D.M., B.L. Sullivan, B.E. Sha, and G.T. Spear. 1998. Mechanisms of resistance of HIV-1 primary isolates to complement-mediated lysis. Virology. 246:370-378.
53. Bachmann, M.F., and R.M. Zinkernagel. 1996. Virus structure, antibody response and virus serotypes. Immunol. Today. 17:553-558.
54. Da Costa, X.J., M.A. Brockman, E. Alicot, M. Ma, M.B. Fischer, X. Zhou, D.M. Knipe, and M.C. Carroll. 1999. Humoral response to herpes simplex virus is complement dependent. Proc. Natl. Acad. Sci. USA. In press.
55. Buiting, A.M.J., Z. De Rover, G. Kraal, and N. van Rooijen. 1996. Humoral immune responses against particulate bacterial antigens are dependent on marginal metallophilic macrophages in the spleen. Scand. J. Immunol. 43:398-405.
56. Ramshaw, I., J. Ruby, A. Ramsay, G. Ada, and G. Karupiah. 1992. Expression of cytokines by recombinant vaccinia viruses: a model for studying cytokines in viral infections in vivo. Immunol. Rev. 127:157-182.
57. Seiler, P., M.A. Brundler, C. Zimmermann, D. Weibel, M. Bruns, H. Hengartner, and R.M. Zinkernagel. 1998. Induction of protective cytotoxic T cell responses in the presence of high titers of virus-neutralizing antibodies: implications for passive and active immunization. J. Exp. Med. 187:649-654.
58. Seiler, P., U. Kalinke, T. Rulicke, E.M. Bucher, C. Bose, R.M. Zinkernagel, and H. Hengartner. 1998. Enhanced virus clearance by early inducible lymphocytic choriomeningitis virus-neutralizing antibodies in immunoglobulin-transgenic mice. J. Virol. 72:2253-2258.